Adrenal Insufficiency Global Clinical Trials Review, H2, 2015
Summary
GlobalDatas clinical trial report, “Adrenal Insufficiency Global Clinical Trials Review, H2, 2015" provides an overview of Adrenal Insufficiency clinical trials scenario. This report provides top line data relating to the clinical trials on Adrenal Insufficiency. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Datas proprietary database Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
The report provides a snapshot of the global clinical trials landscape
Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
The Report provides enrollment trends for the past five years
Report provides latest news for the past three months
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Reasons to buy
Assists in formulating key business strategies with regards to investment
Helps in identifying prominent locations for conducting clinical trials which saves time and cost
Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
Supports understanding of trials count and enrollment trends by country in global therapeutics market
Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
Facilitates clinical trial assessment of the indication on a global, regional and country level
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Table Of Contents
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Report Guidance 4
Clinical Trials by Region 5
Clinical Trials and Average Enrollment by Country 6
Top Countries Contributing to Clinical Trials in Asia-Pacific 8
Top Five Countries Contributing to Clinical Trials in Europe 9
Top Countries Contributing to Clinical Trials in North America 10
Top Countries Contributing to Clinical Trials in Middle East and Africa 11
Clinical Trials by G7 Countries: Proportion of Adrenal Insufficiency to Hormonal Disorders Clinical Trials 12
Clinical Trials by Phase in G7 Countries 13
Clinical Trials in G7 Countries by Trial Status 14
Clinical Trials by Phase 15
In Progress Trials by Phase 16
Clinical Trials by Trial Status 17
Clinical Trials by End Point Status 18
Subjects Recruited Over a Period of Time 19
Clinical Trials by Sponsor Type 20
Prominent Sponsors 21
Top Companies Participating in Adrenal Insufficiency Therapeutics Clinical Trials 22
Prominent Drugs 23
Clinical Trial Profile Snapshots 24
Appendix 41
Abbreviations 41
Definitions 41
Research Methodology 42
Secondary Research 42
About GlobalData 43
Contact Us 43
Disclaimer 43
Source 44
List Of Tables
List of Tables
Adrenal Insufficiency Therapeutics, Global, Clinical Trials by Region, 2015* 5
Adrenal Insufficiency Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 6
Adrenal Insufficiency Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 7
Adrenal Insufficiency Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 8
Adrenal Insufficiency Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 9
Adrenal Insufficiency Therapeutics Clinical Trials, North America, Top Countries, 2015* 10
Adrenal Insufficiency Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 11
Proportion of Adrenal Insufficiency to Hormonal Disorders Clinical Trials, G7 Countries (%), 2015* 12
Adrenal Insufficiency Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 13
Adrenal Insufficiency Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 14
Adrenal Insufficiency Therapeutics, Global, Clinical Trials by Phase, 2015* 15
Adrenal Insufficiency Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 16
Adrenal Insufficiency Therapeutics, Global, Clinical Trials by Trial Status, 2015* 17
Adrenal Insufficiency Therapeutics Clinical Trials, Global, by End Point Status, 2015* 18
Adrenal Insufficiency Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 19
Adrenal Insufficiency Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 20
Adrenal Insufficiency Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 21
Adrenal Insufficiency Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 22
Adrenal Insufficiency Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 23
List Of Figures
List of Figures
Adrenal Insufficiency Therapeutics, Global, Clinical Trials by Region (%), 2015* 5
Adrenal Insufficiency Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 6
Adrenal Insufficiency Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 7
Adrenal Insufficiency Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 9
Proportion of Adrenal Insufficiency to Hormonal Disorders Clinical Trials, G7 Countries (%), 2015* 12
Adrenal Insufficiency Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 13
Adrenal Insufficiency Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 14
Adrenal Insufficiency Therapeutics, Global, Clinical Trials by Phase (%), 2015* 15
Adrenal Insufficiency Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 16
Adrenal Insufficiency Therapeutics, Global, Clinical Trials by Trial Status, 2015* 17
Adrenal Insufficiency Therapeutics Clinical Trials, Global, by End Point Status, 2015* 18
Adrenal Insufficiency Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 19
Adrenal Insufficiency Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 20
Adrenal Insufficiency Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 21
Adrenal Insufficiency Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 22
Adrenal Insufficiency Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 23
GlobalData Methodology 42
